Cardiovascular safety of Janus kinase inhibitors in patients with rheumatoid arthritis: systematic review and network meta-analysis

• Váldodahkkit: Qige Wei (Dahkki), Hui Wang (Dahkki), Jianglin Zhao (Dahkki), Zhongping Luo (Dahkki), Chufeng Wang (Dahkki), Chunmei Zhu (Dahkki), Na Su (Dahkki), Shengzhao Zhang (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2023-08-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background: Janus kinase (JAK) inhibitors have emerged as a progressively utilized therapeutic approach for the management of rheumatoid arthritis (RA). However, the complete determination of their cardiovascular safety remains inconclusive. Hence, the primary objective of this network meta-analysis...